Klindamicin hameln 150 mg/ml otopina za injekciju / infuziju
Name | Klindamicin hameln 150 mg/ml otopina za injekciju / infuziju |
---|---|
Marketing Authorisation Number | HR-H-115926948 |
Active Substance | klindamicinfosfat |
Composition | svaki ml otopine sadrži klindamicinfosfat koji odgovara 150 mg klindamicina |
Pharmaceutical Form | Otopina za injekciju / infuziju |
Manufacturer | hameln rds, Modra, Slovačka
Siegfried Hameln GmbH, Hameln, Njemačka |
Marketing Authorisation Holder | hameln pharma gmbh, Inselstrasse 1, Hameln, Njemačka |
Marketing Authorisation Date | 06.05.2021 |
MA Period of Validity | 06.05.2026 |
Classification Number | UP/I-530-09/19-01/102 |
Registration Number | 381-12-01/70-21-04 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | J01FF01 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |